Neuro-Oncology

Published by: Oxford University Press  

People

  1. De Angelis
    De Angelis
  2. Kaley
    Kaley
  3. Avila
    Avila
  4. Brennan
    Brennan
  5. Chakravarty
    Chakravarty
  6. Chan
    Chan
  7. Chen
    Chen
  8. Dahi
    Dahi
  9. Giralt
    Giralt
  10. Lin
    Lin

Groups

  1. Center for Hematologic Malignancies (6)
  2. Department of Medicine (6)
  3. Hematologic Malignancies, Division of (6)
  4. Lymphoma (6)
  5. Survivorship Research (4)
  6. Bone Marrow Transplant (3)
  7. Tow Center for Developmental Oncology (TCDO) (3)
  8. Critical Care Center Leadership (2)
  9. Critical Care Center (2)
  10. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1)
Search Within
  1. "Lymphoma"
Formats
  1. Meeting Abstract (5)
  2. Journal Article (1)
Groups
  1. Center for Hematologic Malignancies (6)
  2. Department of Medicine (6)
  3. Hematologic Malignancies, Division of (6)
  4. Lymphoma (6)
  5. Survivorship Research (4)
  6. Bone Marrow Transplant (3)

More Groups

People
  1. Antonio Omuro (3)
  2. Craig Sauter (3)
  3. Lisa De Angelis (3)
  4. Matthew Matasar (3)
  5. Craig Moskowitz (2)
  6. Lauren Abrey (2)

More People

Years
  1. 2019 (1)
  2. 2018 (1)
  3. 2017 (1)
  4. 2013 (2)
  5. 2012 (1)
Publishers
  1. Oxford University Press (6)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Incidence and behavior of central nervous system involvement in patients with Hodgkin's lymphoma
    Meeting Abstract

    Silva Correia, C. E.; Malani, R.; DeAngelis, L.; Moskowitz, A.
    Neuro-Oncology (2019)

    Fulltext@MSK | Save
  • Clinical neurological features and electrographic patterns of patients with relapsed or refractory large B-cell lymphoma treated with axicabtagene ciloleucel at Memorial Sloan Kettering Cancer Center (MSKCC)
    Meeting Abstract

    Sequeira, A.; Mao, D.; Chen, X.; Avila, E.; Mead, E.; Sauter, C. S.; Palomba, M. L.; Dahi, P. B.; Batlevi, C. L.; Shah, G.; more...
    Neuro-Oncology (2018)

    Fulltext@MSK | Save
  • Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma
    Journal Article

    Thomas, A. A.; Abrey, L. E.; Terziev, R.; Raizer, J.; Martinez, N. L.; Forsyth, P.; Paleologos, N.; Matasar, M.; Sauter, C. S.; Moskowitz, C.; more...
    Neuro-Oncology (2017)

    Fulltext@MSK | Save
  • Use of high-dose methotrexate (Hd-Mtx) in leptomeningeal metastasis (LM) in patients with breast cancer
    Meeting Abstract

    Tsyvkin, E.; Rauschkolb, P.; Pentsova, E.
    Neuro-Oncology (2013)

    Fulltext@MSK | Save
  • Temozolomide followed by high-dose chemotherapy and autologous stem cell transplant (Hdc-Asct) for newly diagnosed anaplastic oligodendroglioma (AO): Can radiotherapy be deferred?
    Meeting Abstract

    Omuro, A.; Abrey, L.; Raizer, J.; Paleologos, N.; Forsyth, P.; DeAngelis, L.; Kaley, T.; Louis, D.; Cairncross, J. G.; Matasar, M.; more...
    Neuro-Oncology (2013)

    Fulltext@MSK | Save
  • Histiocytic sarcoma of the central nervous system: A case report
    Meeting Abstract

    Curry, R.; Joyce, J.; Rosenblum, M.; Jaffe, E.; Matasar, M.; Lin, O.; Fisher, R.; Omuro, A.
    Neuro-Oncology (2012)

    Fulltext@MSK | Save

    • Neuro-Oncology – authorized name for:

    Name ISSN / ISBN Publisher
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press On Behalf of the Society for Neuro Oncology
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-oncology 15235866 Unknown
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 15228517 The Author(s)
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 15228517 Oxford University Press On Behalf of the Society for Neuro Oncology
    Neuro-Oncology 1522-8517 Carden Jennings Publ Co Ltd
    Neuro-Oncology 1522-8517 Duke University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 15228517 Unknown
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 15228517 The Author(s) 2023
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press
    Neuro-oncology 15235866 Oxford University Press On Behalf of the Society for Neuro Oncology
    Neuro-Oncology 1522-8517 Duke University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1523-5866 Oxford University Press On Behalf of the Society for Neuro Oncology
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Oxford University Press
    Neuro-Oncology 1522-8517 Society for Neuro Oncology